|
Diaz-Garcia C, Valverde-Molina J, Martinez-Gimeno A, Anton-Pacheco Sanchez JL. Quality of life in children with diseases causing central airway obstruction: Reliability and validity of the TAPQOL questionnaire. Pediatr Pulmonol. 2023 Jan;58(1):279-287. doi: 10.1002/ppul.26198. Epub 2022 Oct 17. PubMed PMID: 36207999.
AÑO: 2023; IF: 2.7
|
|
Sardon-Prado O., Diaz-Garcia C., Corcuera-Elosegui P., Korta-Murua J., Valverde-Molina J., Sanchez-Solis M. Severe Asthma and Biological Therapies: Now and the Future. Journal of Clinical Medicine. September 2023. 12. 10.3390/jcm12185846
AÑO: 2023; IF: 3.0
|
|
Valverde-Molina J, Fernandez-Nieto M, Torres-Borrego J, Lozano Blasco J, de Mir-Messa I, Blanco-Aparicio M, Nieto A, Figuerola Mulet J, Moure AL, Sanchez-Herrero MG, Sanchez-Garcia S. Transition of Adolescents With Severe Asthma From Pediatric to Adult Care in Spain: The STAR Consensus. J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):179-189. doi: 10.18176/jiaci.0780. Epub 2022 Jan 14. PubMed PMID: 35029151.
AÑO: 2023; IF: 6.1
|
|
Miralles-Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, Flores-Martin I, Alemany-Frances ML, Pajaron-Fernandez MJ, Mora-Gonzalez A, Cabrejos-Perotti S, El-Molaka Z, Meseguer-Arce J, Aviles-Ingles MJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR Group. Analysis of response of severe eosinophilic asthmatic patients to benralizumab. Allergol Immunopathol (Madr). 2022 Nov 1;50(6):163-168. doi: 10.15586/aei.v50i6.704. eCollection 2022. PubMed PMID: 36335460.
AÑO: 2022; IF: 1.8
|
|
Miralles Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, Flores-Martin I, Alemany-Frances ML, Pajaron-Fernandez MJ, Mora Gonzalez A, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice. J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):220-223. doi: 10.18176/jiaci.0793. Epub 2022 Feb 15. No abstract available. PubMed PMID: 35166673.
AÑO: 2022; IF: 7.2
|